Profiling endogenous adrenal function during veno-venous ECMO support in COVID-19 ARDS: a descriptive analysis

Front Endocrinol (Lausanne). 2024 Jan 25:14:1321511. doi: 10.3389/fendo.2023.1321511. eCollection 2023.

Abstract

Background: Prolonged critical illness is often accompanied by an impairment of adrenal function, which has been frequently related to conditions complicating patient management. The presumed connection between hypoxia and the pathogenesis of this critical- illness- related corticosteroid insufficiency (CIRCI) might play an important role in patients with severe acute respiratory distress syndrome (ARDS). Since extracorporeal membrane oxygenation (ECMO) is frequently used in ARDS, but data on CIRCI during this condition are scarce, this study reports the behaviour of adrenal function parameters during oxygenation support with veno-venous (vv)ECMO in coronavirus disease 2019 (COVID-19) ARDS.

Methods: A total of 11 patients undergoing vvECMO due to COVID-19 ARDS at the Medical University of Vienna, who received no concurrent corticosteroid therapy, were retrospectively included in this study. We analysed the concentrations of cortisol, aldosterone, and angiotensin (Ang) metabolites (Ang I-IV, Ang 1-7, and Ang 1-5) in serum via liquid chromatography/tandem mass spectrometry before, after 1 day, 1 week, and 2 weeks during vvECMO support and conducted correlation analyses between cortisol and parameters of disease severity.

Results: Cortisol concentrations appeared to be lowest after initiation of ECMO and progressively increased throughout the study period. Higher concentrations were related to disease severity and correlated markedly with interleukin-6, procalcitonin, pH, base excess, and albumin during the first day of ECMO. Fair correlations during the first day could be observed with calcium, duration of critical illness, and ECMO gas flow. Angiotensin metabolite concentrations were available in a subset of patients and indicated a more homogenous aldosterone response to plasma renin activity after 1 week of ECMO support.

Conclusion: Oxygenation support through vvECMO may lead to a partial recovery of adrenal function over time. In homogenous patient collectives, this novel approach might help to further determine the importance of adrenal stress response in ECMO and the influence of oxygenation support on CIRCI.

Keywords: acute respiratory distress syndrome; cortisol; critical illness related corticosteroid insufficiency; extracorporeal membrane oxygenation; severe coronavirus disease 2019.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aldosterone
  • COVID-19* / complications
  • COVID-19* / therapy
  • Critical Illness
  • Extracorporeal Membrane Oxygenation* / methods
  • Humans
  • Hydrocortisone
  • Respiratory Distress Syndrome* / therapy
  • Retrospective Studies

Substances

  • Hydrocortisone
  • Aldosterone

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was mainly funded by a grant from the Medical Scientific Fund of the Mayor of the City of Vienna (Project number: 19040) attributed to MH, as well as in parts by a grant from the Medical Scientific Fund of the Mayor of the City of Vienna (Project number: COVID032) attributed to PW.